These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4214836)

  • 1. Sanfilippo A syndrome: sulfamidase deficiency in cultured skin fibroblasts and liver.
    Matalon R; Dorfman A
    J Clin Invest; 1974 Oct; 54(4):907-12. PubMed ID: 4214836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharide substrates for heparin sulfamidase.
    Thompson JN; Rodén L; Reynertson R
    Anal Biochem; 1986 Feb; 152(2):412-22. PubMed ID: 3083713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharide storage diseases and lysosomal hydrolases in cultured fibroblasts.
    den Tandt WR; Schaberg A
    Pathol Eur; 1973; 8(1):3-11. PubMed ID: 4269628
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
    Perkins KJ; Muller V; Weber B; Hopwood JJ
    Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
    Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U
    Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient.
    Gordon BA; Feleki V; Budreau CH; Tyler L
    Clin Biochem; 1975 Jun; 8(3):184-93. PubMed ID: 238759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1981 Apr; 112(1):55-66. PubMed ID: 6786803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of sulfate-containing acid mucopolysaccharides in I-cell fibroblasts.
    Schmickel RD; Distler JJ; Jourdian GW
    J Lab Clin Med; 1975 Oct; 86(4):672-82. PubMed ID: 170349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanfilippo syndrome, type D: a spectrophotometric assay with prenatal diagnostic potential.
    Nowakowski RW; Thompson JN; Taylor KB
    Pediatr Res; 1989 Nov; 26(5):462-6. PubMed ID: 2510119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis 3 A (Sanfilippo A disease): deficiency of a heparin sulfamidase in skin fibroblasts and leucocytes.
    Kresse H
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1111-8. PubMed ID: 4201808
    [No Abstract]   [Full Text] [Related]  

  • 11. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.
    Kresse H; Von Figura K; Klein U
    Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A screening method for mucopolysaccharidoses with increased urinary excretion of sulfated N-acetylhexosamines.
    Nowakowski RW; Thompson JN; Edge DS
    Biochem Int; 1990 Nov; 22(3):419-26. PubMed ID: 2127527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1982 Aug; 123(3):241-50. PubMed ID: 6811162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients.
    O'Brien JS
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1720-2. PubMed ID: 4261742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblasts.
    von Figura K; Kresse H
    J Clin Invest; 1974 Jan; 53(1):85-90. PubMed ID: 4271574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings.
    Cain H; Egner E; Kresse H
    Beitr Pathol; 1977 Apr; 160(1):58-72. PubMed ID: 405006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5185-9. PubMed ID: 33384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosidases in human skin fibroblast cultures. Alpha-fucosidase, alpha-galactosidase, alpha-glucosidase, beta-mannosidase, and N-acetyl-alpha-glucosaminidase.
    Hultberg B; Sjöblad S; Ockerman PA
    Acta Paediatr Scand; 1975 Jan; 64(1):123-31. PubMed ID: 234663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
    Kresse H; Paschke E; von Figura K; Gilberg W; Fuchs W
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6822-6. PubMed ID: 6450420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.